We are live on ! Find out more
DA

Dunvegan Associates Portfolio holdings

AUM $85.1M
1-Year Est. Return 2.3%
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
-2.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$14.1M
Cap. Flow
-$24.1M
Cap. Flow %
-19.92%
Top 10 Hldgs %
50.71%
Holding
86
New
3
Increased
6
Reduced
45
Closed
16

Top Buys

Rank Stock Value
1
ABEV icon
Ambev
ABEV
+$2.05M
2
GLD icon
SPDR Gold Trust
GLD
+$1.24M
3
PG icon
Procter & Gamble
PG
+$214K
4
ABB
ABB Ltd
ABB
+$196K
5
COST icon
Costco
COST
+$119K

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$3.77M
2
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
+$3.47M
3
TRP icon
TC Energy
TRP
+$2.25M
4
THD icon
iShares MSCI Thailand ETF
THD
+$1.8M
5
ENB icon
Enbridge
ENB
+$1.63M

Sector Composition

Rank Sector Weight
1 Miscellaneous 22.06%
2 Energy 21.02%
3 Financials 14.52%
4 Healthcare 11.67%
5 Consumer Staples 10.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
1
Mastercard
MA
$521B
$12.1M 9.96%
144,510
-10,440
-7% -$775K
GLD icon
2
SPDR Gold Trust
GLD
$149B
$8.39M 6.92%
72,234
+10,097
+16% +$1.24M
MKC icon
3
McCormick & Company Non-Voting
MKC
$14.9B
$7.31M 6.03%
212,226
-9,994
-4% -$341K
WPZ
4
DELISTED
Williams Partners L.P.
WPZ
$6.27M 5.17%
117,608
-7,518
-6% -$368K
MON
5
DELISTED
Monsanto Co
MON
$5.89M 4.86%
50,505
-2,337
-4% -$255K
LNG icon
6
Cheniere Energy
LNG
$58.3B
$5.06M 4.17%
117,273
-17,430
-13% -$694K
V icon
7
Visa
V
$712B
$4.93M 4.07%
88,620
-8,432
-9% -$425K
NVS icon
8
Novartis
NVS
$292B
$4.2M 3.47%
58,334
-2,341
-4% -$163K
AGN
9
DELISTED
Allergan Inc
AGN
$3.83M 3.16%
34,498
-999
-3% -$95.4K
ENB icon
10
Enbridge
ENB
$110B
$3.5M 2.89%
80,252
-38,732
-33% -$1.63M
TRP icon
11
TC Energy
TRP
$64.4B
$2.82M 2.32%
61,723
-50,503
-45% -$2.25M
UPS icon
12
United Parcel Service
UPS
$89.6B
$2.74M 2.26%
26,069
-2,652
-9% -$261K
AMLP icon
13
Alerian MLP ETF
AMLP
$13.4B
$2.71M 2.24%
30,493
+212
+0.7% +$18.6K
ACN icon
14
Accenture
ACN
$116B
$2.71M 2.23%
32,896
-2,201
-6% -$166K
LLY icon
15
Eli Lilly
LLY
$1.05T
$2.61M 2.15%
51,219
-462
-0.9% -$23.1K
NVO
16
Novo Nordisk
NVO
$202B
$2.37M 1.96%
128,430
-6,050
-4% -$105K
MMM icon
17
3M
MMM
$89.9B
$2.35M 1.94%
20,071
– –
IBB icon
18
iShares Biotechnology ETF
IBB
$10.5B
$2.1M 1.73%
27,738
-6,159
-18% -$437K
IRL
19
DELISTED
NEW IRELAND FUND INC
IRL
$2.1M 1.73%
163,329
-72,163
-31% -$888K
CLR
20
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$2.09M 1.72%
37,070
-3,986
-10% -$223K
ABEV icon
21
Ambev
ABEV
$44.1B
$2.06M 1.7%
+280,375
New +$2.05M
TEF
22
DELISTED
Telefonica
TEF
$1.91M 1.58%
159,633
-2,172
-1% -$26.3K
EWI icon
23
iShares MSCI Italy ETF
EWI
$1.12B
$1.91M 1.57%
61,095
-852
-1% -$25.8K
UGP icon
24
Ultrapar
UGP
$6.87B
$1.84M 1.52%
155,826
-120,434
-44% -$1.53M
MOS icon
25
The Mosaic Company
MOS
$7.5B
$1.77M 1.46%
37,493
-12,458
-25% -$578K
1
2 3 4

Similar funds

TSBJ
Trevor, Stewart, Burton & Jacobsen New York $88.4M AUM 7.43% 1-Year Est. Return
VCAM
Valentine Capital Asset Management Danville, California $89.6M AUM 0.84% 1-Year Est. Return
KCA
KR Capital Advisors New York $80M AUM 4.21% 1-Year Est. Return
TP
TB Partners Shanghai, China $90.9M AUM
SPC
Standard Pacific Capital San Francisco, California $92M AUM 5.65% 1-Year Est. Return
ST
Semper Trust King Of Prussia, Pennsylvania $71.9M AUM
CGC
Cloud Gate Capital Chicago, Illinois $70.7M AUM 11.83% 1-Year Est. Return
GCG
Giovine Capital Group Santa Monica, California $68.7M AUM 2.56% 1-Year Est. Return

Dunvegan Associates's Q4 2013 Portfolio in Review

As of Q4 2013, Dunvegan Associates held 86 positions worth $121M, down 10% from $135M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Dunvegan Associates withdrew a net $24.1M in Q4 2013, closing 16 positions and reducing 45 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 22% a quarter earlier, followed by Energy and Financials.

Against the trend, Dunvegan Associates opened a new position in Ambev worth $2.06M.

  • Dunvegan Associates's largest Q4 2013 buy was Ambev: 280,375 shares worth $2.06M.
  • Dunvegan Associates added most to SPDR Gold Trust in Q4 2013, an estimated $1.24M increase.
  • Dunvegan Associates's biggest Q4 2013 reduction was TC Energy, cutting an estimated $2.25M.
  • Dunvegan Associates fully exited Meta Platforms (Facebook) in Q4 2013, selling an estimated $3.77M.
  • Dunvegan Associates's ten largest holdings make up 51% of its $121M portfolio in Q4 2013.
  • Dunvegan Associates opened 3 new positions and closed 16 in Q4 2013.
  • Dunvegan Associates's portfolio value fell 10% quarter-over-quarter to $121M.

Based on Dunvegan Associates's 13F filing for Q4 2013, filed 21 Feb 2014.